DrugsControl Media Services

News Detail

US FDA issues draft guidance for peptide drug products (15-09-2023)

Maryland, 14 Sept 2023: The US Food and Drug Administration (FDA) has released a draft guidance outlining the agency’s clinical pharmacology and labeling considerations for peptide drug products.
When finalized, the guidance will represent the agency’......
View Details

Source : Regulatory Focus
US Food and Drug Administration (FDA) draft guidance peptide drug products

Related News